Pseudomonas aeruginosa Diversifies Inside Cells to Form an Adaptive Niche that Resists Antibiotic Treatment – Naren Gajenthra Kumar, BTech, PhD

Dr. Naren G. Kumar, a postdoctoral research scholar at the University of California Berkeley, presents results from CFRI-funded research on characterizing the intracellular diversification of Pseudomonas aeruginosa in chronic lung infections. Findings from experiments suggest that P. aeruginosa undergoes adaptive phenotypic changes in response to the intracellular microenvironment that favor the development of antibiotic-resistant sub-populations. This presentation was part of CFRI's Virtual 35th National CF Education Conference on July 31, 2022.

CFRI's 35th National CF Education Conference was sponsored by Vertex Pharmaceuticals, Genentech, Gilead Sciences, Chiesi USA, AbbVie, and Ionis Pharmaceuticals.